Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer

Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Neoadjuvant abemaciclib for HR positive, HER negative breast cancer ( Dr Sara Hurvitz - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

TCHP with/out oestrogen for HR/HER positive breast cancer

Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA

TCHP with/out oestrogen for HR/HER positive breast cancer ( Dr Mothaffar Rimawi - Baylor College of Medicine, Houston, USA )

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in...

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

Efficacy of veliparib with carboplatin and paclitaxel for BRCA1/2 mutations in metastatic breast cancer ( Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA )

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition

Dr Terry Mamounas - UF Health Center, Orlando, USA

Extended adjuvant endrocine therapy with letrozole after aromatase inhibition ( Dr Terry Mamounas - UF Health Center, Orlando, USA )

Whole exome and transcriptome sequencing of resistant ER positive metastatic...

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast...

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

PrECOG: Added everolimus extends PFS for HR positive, HER2 negative breast cancer ( Dr Noah Kornblum - Montefiore Medical Center, New York, USA )

ASH 2016: Multiple myeloma highlights

Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig

ASH 2016: Multiple myeloma highlights ( Prof Marivi Mateos, Prof Philippe Moreau, Prof Saad Usmani, Prof Heinz Ludwig )

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin...

Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA

Interim results from the ZUMA-1 trial of novel CAR-T cells against non-Hodgkin lymphoma ( Dr Sattva Neelapu - MD Anderson Cancer Center, Houston, USA )

Pacritinib versus best available therapy for low platelet Myelofibrosis

Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA

Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )

Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL

Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA

Dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL ( Dr Zanetta Lamar - Wake Forest Baptist Medical Center, Winston-Salem, USA )

DVd vs Vd for relapsed or refractory myeloma: CASTOR trial update

Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain

$DVd vs Vd for relapsed or refractory myeloma: CASTOR trial update ( Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain )$

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy

ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )

More from ecancer